We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMTM
576
Amentum Holdings
AMTM
$5.73B
$459K 0.05%
+14,246
New +$406K
GTY
577
Getty Realty Corp
GTY
$2.12B
$458K 0.05%
+14,400
New +$441K
BHC icon
578
Bausch Health
BHC
$1.69B
$458K 0.05%
56,100
-88,732
-61% -$585K
HCAT icon
579
Health Catalyst
HCAT
$158M
$456K 0.05%
56,001
+19,963
+55% +$144K
SPNS
580
DELISTED
Sapiens International
SPNS
$456K 0.05%
12,228
+2,844
+30% +$104K
ASPN icon
581
Aspen Aerogels
ASPN
$364M
$455K 0.05%
16,435
+7,819
+91% +$196K
NVGS icon
582
Navigator Holdings
NVGS
$1.34B
$454K 0.05%
28,277
-17,455
-38% -$285K
GRAB icon
583
Grab
GRAB
$14.1B
$452K 0.05%
118,995
+18,198
+18% +$62K
SNOW icon
584
Snowflake
SNOW
$93.7B
$451K 0.05%
3,928
-7,245
-65% -$891K
EQC
585
DELISTED
Equity Commonwealth
EQC
$449K 0.05%
+22,553
New +$449K
HOUS
586
DELISTED
Anywhere Real Estate
HOUS
$448K 0.05%
88,246
+28,607
+48% +$133K
RSKD icon
587
Riskified
RSKD
$720M
$442K 0.05%
93,469
+11,349
+14% +$62K
USLM icon
588
United States Lime & Minerals
USLM
$3.26B
$442K 0.05%
+4,522
New +$363K
HCKT icon
589
Hackett Group
HCKT
$266M
$436K 0.05%
16,594
+3,894
+31% +$97.7K
CMA
590
DELISTED
Comerica
CMA
$435K 0.05%
+7,253
New +$400K
ATEC icon
591
Alphatec Holdings
ATEC
$1.43B
$432K 0.05%
77,780
+62,978
+425% +$483K
CM icon
592
Canadian Imperial Bank of Commerce
CM
$109B
$431K 0.05%
+7,034
New +$381K
MAS icon
593
Masco
MAS
$16.5B
$430K 0.05%
+5,125
New +$388K
MMSI icon
594
Merit Medical Systems
MMSI
$4.67B
$429K 0.05%
+4,340
New +$397K
CDP icon
595
COPT Defense Properties
CDP
$4.34B
$426K 0.05%
+14,055
New +$400K
ELV icon
596
Elevance Health
ELV
$83.7B
$425K 0.05%
818
-570
-41% -$305K
WBA
597
DELISTED
Walgreens Boots Alliance
WBA
$424K 0.05%
+47,349
New +$487K
LII icon
598
Lennox International
LII
$18.9B
$424K 0.05%
+701
New +$400K
MORN icon
599
Morningstar
MORN
$7.38B
$423K 0.05%
+1,327
New +$412K
ABR icon
600
Arbor Realty Trust
ABR
$979M
$422K 0.05%
27,150
+3,722
+16% +$51.7K
22 23
24
25 26

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.